INHA

INHA
Name	Inhibin alpha chain
Uniprot	P05111
Organism	Homo sapiens
Gene location	Chromosome 2p16
Length	426 aa (precursor)
Family	TGF-beta superfamily

INHA

INHA is a human gene encoding the inhibin alpha chain, a member of the transforming growth factor-beta (TGF-β) superfamily that forms secreted heterodimeric hormones known as inhibins. The inhibin alpha subunit combines with beta subunits to generate peptide hormones that modulate endocrine axes, notably interacting with activins and follistatin-related pathways. The gene and protein have been studied across contexts including reproductive physiology, tumor biology, and developmental signaling.

Introduction

The INHA locus was mapped to chromosome 2p16 during positional cloning studies and has been characterized in comparative analyses alongside homologs from species such as Mus musculus, Rattus norvegicus, Bos taurus, Gallus gallus, and Danio rerio. Landmark research into reproductive endocrinology by investigators at institutions like the National Institutes of Health, Johns Hopkins University, and the University of Cambridge helped define inhibin's role in feedback control of the hypothalamic–pituitary–gonadal axis. Seminal papers published in journals including Nature, Science, The Journal of Clinical Investigation, Endocrinology, and Proceedings of the National Academy of Sciences documented isolations of inhibin peptides and the alpha subunit's gene sequence.

Gene and Protein Structure

The INHA gene spans multiple exons and encodes a precursor polypeptide composed of a signal peptide, a pro-region (pro-α), and a mature C-terminal domain that adopts a cystine-knot fold characteristic of TGF-β family members. The precursor undergoes proteolytic processing by proprotein convertases such as furin, producing an α N-terminal propeptide (pro-α) and a mature α C-terminal peptide that forms disulfide-linked dimers. Structural studies using X-ray crystallography and solution NMR on related TGF-β family members from groups at the European Molecular Biology Laboratory, the Max Planck Institute, and Harvard Medical School informed models of the inhibin heterodimer interface, including residues essential for receptor engagement. Comparative genomics with data from Ensembl, GenBank, and UniProt highlights conserved cysteines, cleavage motifs, and glycosylation sites across vertebrate orthologs.

Function and Biological Role

The inhibin alpha chain pairs with betaA or betaB subunits (encoded by INHBA and INHBB) to form inhibin A and inhibin B, respectively; these heterodimers antagonize activin signaling by binding to activin type II receptors and modulating downstream SMAD transcription factors. Inhibins exert paracrine and endocrine functions in the ovary, testis, pituitary gland, adrenal cortex, and placenta, contributing to folliculogenesis, Sertoli cell function, and regulation of follicle-stimulating hormone (FSH) release. Studies from laboratories associated with the Howard Hughes Medical Institute, the University of Oxford, and the University of California delineated roles for inhibin in granulosa cell differentiation, luteinization, and paracrine cross-talk with bone morphogenetic proteins (BMPs), WNT family members, and gonadotropin signaling cascades. In non-reproductive tissues, inhibin/activin balance influences processes studied by groups at the Salk Institute and Cold Spring Harbor Laboratory, including inflammation, fibrosis, and embryonic axis formation.

Clinical Significance and Disorders

Alterations in INHA expression or function have clinical correlations in reproductive disorders and neoplasia. Loss-of-function mutations or downregulation of the alpha subunit have been observed in granulosa cell tumors and adrenocortical carcinomas, with clinical investigations led by teams at Memorial Sloan Kettering Cancer Center and the Mayo Clinic using inhibin as a serum biomarker. Conversely, elevated inhibin levels are exploited in prenatal screening protocols researched by perinatal centers such as King's College Hospital and Mount Sinai to assess Down syndrome risk. Animal model studies from institutions such as The Jackson Laboratory and the European Molecular Biology Organization showed that Inha knockout mice develop gonadal stromal tumors and cachexia-like syndromes, underscoring tumor suppressor-like roles. Clinical trials and translational research at academic medical centers have explored inhibin/activin pathway modulators for infertility, cancer, and fibrotic disease.

Interactions and Regulation

The inhibin alpha chain participates in protein–protein interactions with beta subunits (INHBA, INHBB), betaglycan (also called TGFBR3), activin type II receptors (ACVR2A, ACVR2B), follistatin (FST), and extracellular matrix components. Regulation occurs at transcriptional and post-translational levels: transcription factors such as FOXL2, GATA4, SF-1 (NR5A1), and WT1 modulate promoter activity in gonadal cells; microRNAs and epigenetic marks influence INHA mRNA stability; and proteolytic processing by proprotein convertases controls bioactive peptide release. Cross-regulatory circuits involve signaling nodes studied by researchers at Stanford University, Imperial College London, and Kyoto University, linking inhibin to SMAD proteins, MAPK cascades, and nuclear co-regulators that integrate developmental and endocrine cues.

Research and Experimental Studies

Experimental approaches include gene knockout and transgenic mouse models, in vitro assays in granulosa and Sertoli cell lines, recombinant protein production, and structural biology elucidation. High-throughput screens at consortia like the Human Protein Atlas and the ENCODE Project mapped expression patterns and regulatory elements. Clinical cohorts and biobanks at institutions such as the Broad Institute and the European Prospective Investigation into Cancer and Nutrition provided epidemiological correlations between inhibin levels and disease outcomes. Current research directions involve therapeutic targeting of activin–inhibin balance with ligand traps, monoclonal antibodies, and small molecules developed in academic–industry collaborations, as exemplified by programs at biotech firms and university spinouts focusing on reproductive medicine and oncology.

Category:Human proteinsCategory:TGF-beta superfamily